[1]
Ribeiro, T. et al. 2020. Critical appraisal of cost-effectiveness studies of oncologic drugs recommended for incorporation by the Conitec in Brazil . Jornal Brasileiro de Economia da Saúde. 12, 2 (Aug. 2020), 155–163. DOI:https://doi.org/10.21115/JBES.v12.n2.p155-63.